MX365381B - Métodos para la inactivación viral y de otros agentes adventicios. - Google Patents

Métodos para la inactivación viral y de otros agentes adventicios.

Info

Publication number
MX365381B
MX365381B MX2014015751A MX2014015751A MX365381B MX 365381 B MX365381 B MX 365381B MX 2014015751 A MX2014015751 A MX 2014015751A MX 2014015751 A MX2014015751 A MX 2014015751A MX 365381 B MX365381 B MX 365381B
Authority
MX
Mexico
Prior art keywords
methods
inactivation
viruses
bacteria
cell culture
Prior art date
Application number
MX2014015751A
Other languages
English (en)
Other versions
MX2014015751A (es
Inventor
Ken Shiratori Masaru
David Kiss Robert
Prashad Hardayal
Iverson Raquel
Bourret Justin
Kim Michael
Charaniya Salim
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48746128&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX365381(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of MX2014015751A publication Critical patent/MX2014015751A/es
Publication of MX365381B publication Critical patent/MX365381B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
    • C12N2500/14—Calcium; Ca chelators; Calcitonin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/42—Organic phosphate, e.g. beta glycerophosphate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/60—Buffer, e.g. pH regulation, osmotic pressure
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14061—Methods of inactivation or attenuation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/12011—Bunyaviridae
    • C12N2760/12061—Methods of inactivation or attenuation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16061—Methods of inactivation or attenuation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18061—Methods of inactivation or attenuation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20061—Methods of inactivation or attenuation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16061—Methods of inactivation or attenuation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32061—Methods of inactivation or attenuation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36061—Methods of inactivation or attenuation

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

La presente invención se refiere a métodos de inactivación viral utilizando tratamiento a alta temperatura, de corta duración (HTST) y ajuste de varios parámetros, de manera que se reduce y/o minimiza la generación del precipitado y las deposiciones del precipitado.
MX2014015751A 2012-06-20 2013-06-20 Métodos para la inactivación viral y de otros agentes adventicios. MX365381B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261662349P 2012-06-20 2012-06-20
US13/844,051 US9493744B2 (en) 2012-06-20 2013-03-15 Methods for viral inactivation and other adventitious agents
PCT/US2013/046756 WO2013192395A1 (en) 2012-06-20 2013-06-20 Methods for inactivation of viruses and bacteria in cell culture media

Publications (2)

Publication Number Publication Date
MX2014015751A MX2014015751A (es) 2015-04-10
MX365381B true MX365381B (es) 2019-05-31

Family

ID=48746128

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2014015751A MX365381B (es) 2012-06-20 2013-06-20 Métodos para la inactivación viral y de otros agentes adventicios.
MX2019006336A MX2019006336A (es) 2012-06-20 2014-12-17 Metodos para la inactivacion viral y de otros agentes adventicios.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2019006336A MX2019006336A (es) 2012-06-20 2014-12-17 Metodos para la inactivacion viral y de otros agentes adventicios.

Country Status (22)

Country Link
US (4) US9493744B2 (es)
EP (2) EP2864471B1 (es)
JP (3) JP6607779B2 (es)
KR (2) KR102095073B1 (es)
CN (2) CN115491340A (es)
AR (1) AR091508A1 (es)
AU (2) AU2013277118B2 (es)
BR (1) BR112014031853B1 (es)
CA (1) CA2875997C (es)
DK (1) DK2864471T3 (es)
ES (1) ES2625060T3 (es)
HK (1) HK1210215A1 (es)
HU (1) HUE032812T2 (es)
IL (1) IL236144B (es)
MX (2) MX365381B (es)
MY (1) MY192975A (es)
PL (1) PL2864471T3 (es)
RU (1) RU2685203C2 (es)
SG (2) SG11201408473UA (es)
SI (1) SI2864471T1 (es)
WO (1) WO2013192395A1 (es)
ZA (1) ZA201409172B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9493744B2 (en) 2012-06-20 2016-11-15 Genentech, Inc. Methods for viral inactivation and other adventitious agents
BE1024230B1 (fr) * 2016-11-08 2017-12-20 Univercells Sa Production contenue de cellules et/ou de produits cellulaires
CN112752769A (zh) 2018-08-10 2021-05-04 豪夫迈·罗氏有限公司 用于调节蛋白糖基化的细胞培养策略

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4153509A (en) * 1977-10-17 1979-05-08 Union Carbide Corporation Microbial production of hydroxylated biphenyl compounds
USRE30985E (en) 1978-01-01 1982-06-29 Serum-free cell culture media
GB2048981B (en) 1979-05-23 1982-11-17 Coal Ind Equipment for laying a layer of elongate material adjacent to an exposed rock or mineral surface in an underground mine
USRE30385E (en) 1979-07-16 1980-08-26 American Cyanamid Company Light and heat stabilizers for polyolefins
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4560655A (en) 1982-12-16 1985-12-24 Immunex Corporation Serum-free cell culture medium and process for making same
US4657866A (en) 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
AU2353384A (en) 1983-01-19 1984-07-26 Genentech Inc. Amplification in eukaryotic host cells
US4713339A (en) 1983-01-19 1987-12-15 Genentech, Inc. Polycistronic expression vector construction
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
US4992363A (en) 1983-11-09 1991-02-12 Thomas Jefferson University Method for preparing glucose free media for storing blood platelets
JPH0825902B2 (ja) * 1985-02-21 1996-03-13 株式会社ミドリ十字 γ−グロブリンの加熱処理方法
GB8516415D0 (en) 1985-06-28 1985-07-31 Celltech Ltd Culture of animal cells
US5091178A (en) 1986-02-21 1992-02-25 Oncogen Tumor therapy with biologically active anti-tumor antibodies
US4927762A (en) 1986-04-01 1990-05-22 Cell Enterprises, Inc. Cell culture medium with antioxidant
US4762714A (en) 1986-04-08 1988-08-09 Miles Laboratories, Inc. Preparation of retrovirus-free immunoglobulins
IL87737A (en) 1987-09-11 1993-08-18 Genentech Inc Method for culturing polypeptide factor dependent vertebrate recombinant cells
DE3816139A1 (de) * 1987-10-17 1989-04-27 Bayer Ag Verfahren zur herstellung von paramunitaetsinducern
ES2043794T3 (es) 1987-12-28 1994-01-01 Procter & Gamble Preparacion de bebidas de zumo de fruta suplementadas con calcio dispersando una presion de hidroxido de calcio en una corriente de zumo pasteurizado.
US4872919A (en) 1988-01-28 1989-10-10 The Procter & Gamble Company Method for removing precipitated calcium citrate from juice pasteurization or sterilization equipment
DE68925971T2 (de) 1988-09-23 1996-09-05 Cetus Oncology Corp Zellenzuchtmedium für erhöhtes zellenwachstum, zur erhöhung der langlebigkeit und expression der produkte
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
DE69024369T2 (de) 1989-11-22 1996-06-13 Genentech Inc Latenz assoziierte peptide und deren verwendung
US5122469A (en) 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
GB2251249B (en) 1990-12-28 1995-06-21 Mogam Biotech Res Inst High-density medium for animal cell culture
EP0617706B1 (en) 1991-11-25 2001-10-17 Enzon, Inc. Multivalent antigen-binding proteins
US5378488A (en) 1993-06-10 1995-01-03 Abbott Laboratories Aseptic processing of infant formula
AU695766B2 (en) * 1993-12-01 1998-08-20 Novo Nordisk Biotech, Inc. (Aspergillus) expression system
US5856179A (en) 1994-03-10 1999-01-05 Genentech, Inc. Polypeptide production in animal cell culture
JP3815794B2 (ja) * 1994-09-08 2006-08-30 ジェネンテク・インコーポレイテッド リン酸カルシウムトランスフェクション法
US5484720A (en) 1994-09-08 1996-01-16 Genentech, Inc. Methods for calcium phosphate transfection
US6043092A (en) 1996-03-18 2000-03-28 University Of Pittsburgh Cell culture media for mammalian cells
JP2000512128A (ja) * 1997-03-12 2000-09-19 ユニバーシティ・オブ・ピッツバーグ 哺乳類細胞用の細胞培養培地
AT405608B (de) * 1997-04-08 1999-10-25 Immuno Ag Verfahren zur inaktivierung von pathogenen, insbesondere von viren, in einem biologischen material
PT1200606E (pt) 1999-08-12 2006-12-29 Pfizer Prod Inc Gene de streptomyces avermitilis que regula a proporção de avermectinas b2:b1
WO2002056824A2 (en) * 2000-08-10 2002-07-25 Boston Biomedica, Inc. Pressure cycling inactivation of pathogens in biological materials used for therapeutics or vaccines
WO2003062458A2 (en) * 2002-01-24 2003-07-31 Ecopia Biosciences Inc. Method, system and knowledge repository for identifying a secondary metabolite from a microorganism
GB0304799D0 (en) * 2003-03-03 2003-04-09 Glaxosmithkline Biolog Sa Novel method
WO2004113510A2 (en) 2003-06-18 2004-12-29 Dsm Ip Assets B.V. Production of pantothenate using microorganisms incapable of sporulation
JP4825409B2 (ja) 2004-08-31 2011-11-30 株式会社日本触媒 光学用面状熱可塑性樹脂成形体、これを用いる偏光板および液晶表示装置
CA2600346A1 (en) 2005-03-17 2006-09-28 Hercules Incorporated Process of reducing fouling during heat processing of foods and beverages
CA2738022A1 (en) * 2008-09-24 2010-04-01 Medimmune, Llc Methods for cultivating cells, propagating and purifying viruses
EP3431588A1 (en) 2009-08-11 2019-01-23 F. Hoffmann-La Roche AG Production of proteins in glutamine-free cell culture media
JP5293499B2 (ja) * 2009-08-24 2013-09-18 旭硝子株式会社 リン酸カルシウムの沈着を抑制したコラーゲンビトリゲル
US20150337269A1 (en) 2012-04-10 2015-11-26 Genentech, Inc. Methods for inactivation of viruses and bacteria in cell culture media
US9493744B2 (en) 2012-06-20 2016-11-15 Genentech, Inc. Methods for viral inactivation and other adventitious agents

Also Published As

Publication number Publication date
SG10201707017XA (en) 2017-09-28
CA2875997C (en) 2020-07-21
RU2685203C2 (ru) 2019-04-16
JP2020062019A (ja) 2020-04-23
US20200216799A1 (en) 2020-07-09
US20130344570A1 (en) 2013-12-26
PL2864471T3 (pl) 2017-07-31
AU2013277118A1 (en) 2015-01-22
DK2864471T3 (en) 2017-05-08
BR112014031853A2 (pt) 2017-06-27
KR20200034829A (ko) 2020-03-31
AU2019202400A1 (en) 2019-05-02
US10184106B2 (en) 2019-01-22
JP2015523865A (ja) 2015-08-20
EP2864471A1 (en) 2015-04-29
ZA201409172B (en) 2017-09-27
HK1210215A1 (en) 2016-04-15
CN104603261A (zh) 2015-05-06
HUE032812T2 (en) 2017-11-28
EP3205715A1 (en) 2017-08-16
US20170159010A1 (en) 2017-06-08
SI2864471T1 (sl) 2017-05-31
AR091508A1 (es) 2015-02-11
KR20150020695A (ko) 2015-02-26
MX2019006336A (es) 2022-06-27
WO2013192395A1 (en) 2013-12-27
ES2625060T3 (es) 2017-07-18
IL236144A0 (en) 2015-01-29
RU2015101506A (ru) 2016-08-10
AU2013277118B2 (en) 2019-05-02
SG11201408473UA (en) 2015-01-29
MX2014015751A (es) 2015-04-10
CN115491340A (zh) 2022-12-20
BR112014031853B1 (pt) 2021-09-14
IL236144B (en) 2020-06-30
JP2018019711A (ja) 2018-02-08
EP2864471B1 (en) 2017-03-08
KR102095073B1 (ko) 2020-03-30
US9493744B2 (en) 2016-11-15
JP6607779B2 (ja) 2019-11-20
US20230159886A1 (en) 2023-05-25
CA2875997A1 (en) 2013-12-27
MY192975A (en) 2022-09-20

Similar Documents

Publication Publication Date Title
AU2019232913A1 (en) Methods and processes for non-invasive assessment of genetic variations
IL257009A (en) Cells for immunotherapy are engineered to target the cd38 antigen and inactivate the cd38 gene
MX2018006116A (es) Materiales y metodos para el tratamiento de miopatias basadas en titina y otras titinopatias.
GB2542653A (en) Methods and compositions for treating cells for transplant
SG10201906070XA (en) Compositions and methods for high efficiency in vivo genome editing
MY161252A (en) Viral inactivation using improved solvent-detergent method
PH12014500995A1 (en) Pak inhibitors for the treatment of cell proliferative disorders
MX2014003889A (es) Compuestos antivirales.
IN2015DN02636A (es)
MY184101A (en) Indoles
GB201103062D0 (en) Method
PH12014502112A1 (en) Probiotic derived non-viable material for infection prevention and treatment
MX348981B (es) Composicion para la estimulacion ovarica controlada.
MX363846B (es) Moduladores de oligonucleotido de linfoma linfocitico cronico/linfoma de celulas b 11a (bcl11a) y sus usos.
MY180834A (en) Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
EP3205713A4 (en) Method for culturing 1,4-dioxane-decomposing bacteria, culture medium, and 1,4-dioxane treatment method using 1,4-dioxane-decomposing bacteria
PH12017501028A1 (en) Treatment of retinal degeneration using progenitor cells
MX351818B (es) Compuestos antivirales.
MX2016009021A (es) Esterilizacion de soluciones antisepticas topicas.
MX2019006336A (es) Metodos para la inactivacion viral y de otros agentes adventicios.
MX2019002405A (es) Desactivacion de patogenos en medios biologicos.
MX2013007055A (es) Derivados de sanglifehrina y metodos para su produccion.
PH12015502577B1 (en) Modulation of heparin-binding epidermal growth factor activity for tympanic membrane healing
EP2597949A4 (en) SUBMIKROMETERZUSAMMENSETZUNGEN
PH12018501045A1 (en) Treatment of retinal degeneration using progenitor cells

Legal Events

Date Code Title Description
FG Grant or registration